Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
4.240
+0.700 (19.77%)
At close: Jun 8, 2026, 4:00 PM EDT
4.320
+0.080 (1.89%)
After-hours: Jun 8, 2026, 7:59 PM EDT
Alvotech Employees
Alvotech had 1,279 employees as of December 31, 2025. The number of employees increased by 267 or 26.38% compared to the previous year.
Employees
1,279
Change (1Y)
267
Growth (1Y)
26.38%
Revenue / Employee
$439,439
Profits / Employee
-$63,120
Market Cap
1.33B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,279 | 267 | 26.38% |
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Evotec SE | 4,526 |
| Phibro Animal Health | 2,475 |
| HUTCHMED (China) | 1,796 |
| ANI Pharmaceuticals | 970 |
| Cronos Group | 610 |
| Xeris Biopharma Holdings | 435 |
ALVO News
- 15 hours ago - Alvotech Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 19 hours ago - Alvotech announces FDA acceptance of AVT16 BLA for review - TheFly
- 20 hours ago - Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio® - GlobeNewsWire
- 4 days ago - Alvotech Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 days ago - Alvotech resubmits AVT05 BLAs to FDA - TheFly
- 4 days ago - Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea® - GlobeNewsWire
- 5 days ago - Main Results of 2026 Annual and Extraordinary General Meeting - GlobeNewsWire
- 6 days ago - Alvotech to present at upcoming investor conferences in June - GlobeNewsWire